Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2025-12-26 @ 2:32 AM
NCT ID: NCT00561002
Description: None
Frequency Threshold: 5
Time Frame: Adverse events data were collected from the day of vaccination for 14 days post-vaccination (Influenza Vaccine Primed group) or 42 days post-vaccination (Influenza Vaccine Naïve/Inadequately Primed group)
Study: NCT00561002
Study Brief: Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Influenza Vaccine Naive/Inadequately Primed Participants had no more than one previous lifetime dose of influenza vaccine and received two doses of Fluzone®, on Days 0 and 14. None None 0 23 12 23 View
Influenza Vaccine Primed Participants had previously received 2 injections of Influenza vaccine in the same season and received a single dose of Fluzone® on Day 0. None None 0 9 3 9 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Injection site redness SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Injection site tenderness SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Injection site swelling SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View
Crying SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Somnolence SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 9.0 View
Anorexia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA 9.0 View
Irritability SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA 9.0 View
Malaise SYSTEMATIC_ASSESSMENT General disorders MedDRA 9.0 View